Evaluate’s latest analysis forecasts an $82 billion increase in major product revenues in 2025 – the largest annual growth ...

CagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route of gaining GLP-1RA market share back from ...

Trump's threat of imposing a tariff on Denmark over desires to acquire Greenland has caught the attention of one of the ...

Novo Nordisk emissions grew 23% in 2024, the company said on Wednesday, and will keep rising through the end of the decade as ...

Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.

Ukraine's parliament is expected to vote next week on a law needed to build and start up two new nuclear power units, an ...

The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

Donald Trump is executing a shock-and-awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ...

Heidi Skolnik, New York Times bestselling co-author of “The Whole Body Reset” joins TODAY to break down some nutritional ...

Eyeing an expected leap in demand for contrast media—used in X-rays, CT scans and more—GE HealthCare is upping its stake in ...

Plant-derived proteins are booming in cosmetics for their natural, effective, and eco-friendly benefits, driving UK market growth amid rising beauty trends. Ankush Nikam Future Market Insights, Inc.